MARKET

ORGO

ORGO

Organogenesis Hldgs Inc
NASDAQ
5.22
-0.20
-3.69%
Closed 19:30 03/25 EDT
OPEN
5.56
PREV CLOSE
5.42
HIGH
5.57
LOW
5.05
VOLUME
1.25M
TURNOVER
0
52 WEEK HIGH
6.71
52 WEEK LOW
2.165
MARKET CAP
662.04M
P/E (TTM)
-735.2113
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ORGO last week (0317-0321)?
Weekly Report · 2d ago
Organogenesis Holdings: Solid Finances Protect From Uncertain Environment
Seeking Alpha · 03/18 02:54
Weekly Report: what happened at ORGO last week (0310-0314)?
Weekly Report · 03/17 09:32
Weekly Report: what happened at ORGO last week (0303-0307)?
Weekly Report · 03/10 09:33
Corcept Shares Rise More Than 55% in 6 Months: Here's Why
Barchart · 03/07 11:08
ORGANOGENESIS HOLDINGS INC. <ORGO.O>: MORGAN STANLEY RAISES TARGET PRICE TO $6.00 FROM $4.00
Reuters · 03/05 14:22
Organogenesis Holdings Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 03/05 14:16
Organogenesis Holdings Price Target Raised to $6.00/Share From $4.00 by Morgan Stanley
Dow Jones · 03/05 14:16
More
About ORGO
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of regenerative products to address patient needs across the continuum of care. Its wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier, cross-linked with extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types as a protective barrier and extracellular matrix scaffold. Its sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for the management of open wounds in a surgical setting.

Webull offers Organogenesis Holdings Inc stock information, including NASDAQ: ORGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORGO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ORGO stock methods without spending real money on the virtual paper trading platform.